Genflow Biosciences Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Eric Leire
Chief executive officer
UK£232.0k
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 3.7yrs |
| CEO ownership | 35.6% |
| Management average tenure | no data |
| Board average tenure | 2.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -UK£2m |
| Mar 31 2024 | n/a | n/a | -UK£2m |
| Dec 31 2023 | UK£232k | UK£232k | -UK£2m |
| Sep 30 2023 | n/a | n/a | -UK£1m |
| Jun 30 2023 | n/a | n/a | -UK£1m |
| Mar 31 2023 | n/a | n/a | -UK£1m |
| Dec 31 2022 | UK£235k | UK£235k | -UK£1m |
| Jun 30 2022 | n/a | n/a | -UK£1m |
| Mar 31 2022 | n/a | n/a | -UK£1m |
| Dec 31 2021 | UK£148k | UK£148k | -UK£1m |
| Mar 31 2021 | n/a | n/a | -UK£651k |
Compensation vs Market: Eric's total compensation ($USD291.35K) is below average for companies of similar size in the German market ($USD472.15K).
Compensation vs Earnings: Eric's compensation has been consistent with company performance over the past year.
CEO
Eric Leire (66 yo)
3.7yrs
Tenure
UK£232,008
Compensation
Dr. Eric Patterson Jean Leire, M.D., MBA, was an Independent Director at PHAXIAM Therapeutics S.A. since 2023 until 2024. He serves as Founder and Chief Executive Officer at Genflow Biosciences plc. and se...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 3.7yrs | UK£232.01k | 35.62% € 2.6m | |
| Independent Non-Executive Director | 2.4yrs | UK£30.00k | 0.31% € 22.8k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Chairperson of the Board | 2.4yrs | UK£30.00k | 0.23% € 16.6k | |
| Independent Non-Executive Director | 3.4yrs | UK£30.71k | 0.36% € 26.3k | |
| Independent Non-Executive Director | 2.8yrs | UK£30.71k | 0.34% € 24.5k | |
| Chairman of Scientific Advisory Board | 1.5yrs | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 1.5yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.5yrs | no data | no data |
2.4yrs
Average Tenure
65yo
Average Age
Experienced Board: WQ5's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.